Patients with acromegaly had significantly higher odds of developing leukemia/lymphoma or ovarian, breast, lung, or other cancers, many of which occurred at younger ages than typically seen in the ...

Learn how to manage persistent acromegaly symptoms after normal lab results, including monitoring, causes of lingering issues ...

Treatment well tolerated with a safety profile consistent with standard-of-care (SoC) Increased biochemical response rates (IGF-1≤1xULN) vs SoC at baseline Continuous improvement of acromegaly symptom ...

While the most obvious signs of acromegaly are changes to your facial features and unusual growth in your hands and feet, it also has effects no one else can see. This rare disease is caused by an ...

People with the rare growth hormone disorder acromegaly have a significantly higher risk of developing various types of cancer, often at ages younger than typically seen in the general population, ...

The journal Pituitary has highlighted research led by Manel Puig, head of the Endocrine, Thyroid and Obesity Research Group at the Germans Trias i Pujol Research Institute (IGTP), which explores the ...

LUND, Sweden, April 25, 2025 /PRNewswire/ -- Camurus (NASDAQ STO: CAMX) today announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a ...

Crinetics Pharmaceuticals stock is a 'Buy' rating due to EU approval and strong initial U.S. uptake of Palsonify for ...

SAN DIEGO — Crinetics Pharmaceuticals announced on Sunday that its experimental drug for acromegaly, a rare and serious hormonal disorder, succeeded in a late-stage trial, bringing the San Diego ...

LAS VEGAS — The once-daily oral paltusotine (Palsonify, Crinetics Pharmaceuticals) showed efficacy and safety for the treatment of acromegaly in the first few patients to receive it post approval. And ...